On May 16 and 17, 2022, the FDA’s Center for Drug Evaluation and Research (CDER) and NIH’s National Center for Advancing Translational Sciences (NCATS) will host a jointly sponsored virtual workshop to explore regulatory fitness in rare disease clinical trials.
